Core Viewpoint - 盈健医疗 (01419) reported a revenue of approximately HKD 644.4 million for the year ending June 30, 2025, reflecting a year-on-year increase of about 9.1% [1] - The profit attributable to shareholders was approximately HKD 26.3 million, representing a year-on-year growth of about 8.9% [1] - Basic earnings per share were approximately HKD 0.069, with a final dividend of HKD 0.03 [1] Revenue Growth - The increase in profit was primarily driven by growth in revenue from general medical services, specialized medical services, and dental services [1] - The gross profit also increased, attributed to the overall revenue growth [1]

Core Viewpoint - 盈健医疗 (01419.HK) reported a revenue of approximately HKD 644 million for the fiscal year 2025, reflecting a year-on-year increase of about 9.1% [1] - The profit attributable to the company's owners was approximately HKD 26.3 million, representing a year-on-year increase of about 8.9% [1] - The board proposed a final dividend of HKD 0.03 per share for the fiscal year 2025, up from HKD 0.028 in fiscal year 2024 [1] Revenue and Profit Growth - The company achieved a steady revenue growth despite ongoing adverse economic conditions in Hong Kong, with a revenue increase of approximately 9.1% compared to fiscal year 2024 [1] - The profit attributable to the owners increased by about 8.9% year-on-year, indicating strong financial performance [1] Business Segment Performance - The core business segments maintained balanced growth, with the primary care division showing stable performance driven by network expansion and a strong patient base [1] - The specialty medical division experienced robust revenue growth due to service upgrades and the addition of more specialists, particularly in ophthalmology, pediatric surgery, cardiology, psychiatry, and orthopedics [1] - Despite competitive pressures in the dental segment, overall revenue growth was achieved following the acquisition of Youde Dental in fiscal year 2025 [1]

Core Viewpoint - Yingjian Medical (01419) reported a revenue of approximately HKD 644.4 million for the year ending June 30, 2025, reflecting a year-on-year increase of about 9.1% [1] - The profit attributable to the company's owners was approximately HKD 26.3 million, representing a year-on-year growth of about 8.9% [1] - Basic earnings per share were approximately HKD 0.069, with a final dividend of HKD 0.03 [1] Revenue Growth - The increase in profit was primarily driven by growth in general medical services, specialized medical services, and dental services [1] - Gross profit increased due to the rise in revenue [1]

Group 1 - The core stock price of Yingjian Medical (01419.HK) closed at HKD 1.110 on August 13, down 1.77% from the previous trading day, with an intraday high of HKD 1.160, marking a nearly one-year high [1] - The company experienced a net inflow of HKD 17.59 thousand on that day, with unspecified amounts flowing in and out [1] - Yingjian Medical Group Limited, established in 1997, is one of the largest medical groups in Hong Kong, listed on the Hong Kong Stock Exchange under stock code 1419 [1] Group 2 - The group operates under the brands "Human Health Integrated Medical Centre," "Human Health Medical Centre," and "Perfect Life," providing comprehensive primary healthcare services [1] - Yingjian Medical has over 60 medical centers across Hong Kong, Kowloon, the New Territories, and outlying islands, offering a wide range of services including prevention, health maintenance, diagnosis, and treatment [1] - The company aims to expand its network of medical centers and establish specialized medical service centers, adhering to its corporate culture of "benevolence" to ensure more citizens can access quality healthcare services [1]

7月23日，截至港股收盘，恒生指数上涨1.62%，报25538.07点。盈健医疗（01419.HK）收报0.98港元/ 股，上涨13.95%，成交量109.4万股，成交额101.21万港元，振幅15.12%。 机构评级方面，目前暂无机构对该股做出投资评级建议。 行业估值方面，医疗保健设备和服务行业市盈率（TTM）平均值为-1.96倍，行业中值1.36倍。盈健医疗 市盈率15.56倍，行业排名第25位；其他巨星医疗控股（02393.HK）为0.33倍、京玖康疗（00648.HK） 为0.38倍、医汇集团（08161.HK）为2.35倍、瑞慈医疗（01526.HK）为5.3倍、环球医疗（02666.HK） 为5.38倍。 资料显示，盈健医疗集团有限公司成立于1997年,在香港联合交易所上市(股份代号:1419),是香港最大型 的医疗集团之一。本集团以'盈健综合医务中心(Human Health Integrated Medical Centre)'、'盈健医务中 心(Human Health Medical Centre)'及'优越医疗(PerfectLife)'品牌提供全科医疗服务。集团开设逾60间医 务中心, ...